Yang, Xu
Chen, Bowen
Wang, Yanyu
Wang, Yunchao
Long, Junyu
Zhang, Nan
Xue, Jingnan
Xun, Ziyu
Zhang, Linzhi
Cheng, Jiamin
Lei, Jin
Sun, Huishan
Li, Yiran
Lin, Jianzhen
Xie, Fucun
Wang, Dongxu
Pan, Jie
Hu, Ke
Guan, Mei
Huo, Li
Shi, Jie
Yu, Lingxiang
Zhou, Lin
Zhou, Jinxue
Lu, Zhenhui
Yang, Xiaobo
Mao, Yilei
Sang, Xinting
Lu, Yinying
Zhao, Haitao http://orcid.org/0000-0002-3444-8044
Funding for this research was provided by:
Chinese Academy of Medical Sciences Initiative for Innovative Medicine (2021-I2M-1-061, 2021-1-I2M-003)
CAMS Clinical and Translational Medicine Research Funds (2019XK320006)
CSCO-Hengrui Cancer Research Fund (Y-HR2019-0239, Y-HR2020MS-0414, Y-HR2020QN-0415)
CSCO-MSD Cancer Research Fund (Y-MSDZD2021-0213)
National Ten Thousand Talent Program
Article History
Received: 11 October 2022
Accepted: 27 December 2022
First Online: 8 February 2023
Declarations
:
: Xu Yang, Bowen Chen, Yanyu Wang, Yunchao Wang, Junyu Long, Nan Zhang, Jingnan Xue, Ziyu Xun, Linzhi Zhang, Jiamin Cheng, Jin Lei, Huishan Sun, Yiran Li, Jianzhen Lin, Fucun Xie, Dongxu Wang, Jie Pan, Ke Hu, Mei Guan, Li Huo, Jie Shi, Lingxiang Yu, Lin Zhou, Jinxue Zhou, Zhenhui Lu, Xiaobo Yang, Yilei Mao, Xinting Sang, Yinying Lu, Haitao Zhao declare no conflict of interest.
: This study was performed in accordance with the Declaration of Helsinki, and it was approved by the Institutional Review Board of PUMCH (IRB No. JS-1391) and the Fifth Medical Center of PLAGH (IRB No. KY-2022-4-24-1). Written informed consent was collected from all patients before the application of medication.